CD1A and acute lymphoblastic leukemia: Additionally, FCM can be instrumental in identifying early T-cell precursor ALL (ETP-ALL), where blasts show negativity for CD1a and CD8, while expressing one or more myeloid/stem cell markers.20,21 Identifying poor prognostic factors at the time of diagnosis is essential as this will influence the treatment plan.